DEXCOM INC's ticker is and the CUSIP is 252131AH0. A total of 37 filers reported holding DEXCOM INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $52,692,310 | -9.6% | 23,000,000 | +11.7% | 0.02% | -14.3% |
| Q2 2023 | $58,271,220 | 0.0% | 20,600,000 | 0.0% | 0.03% | 0.0% |
| Q1 2023 | $58,271,220 | +3.6% | 20,600,000 | +1.0% | 0.03% | -3.4% |
| Q4 2022 | $56,250,144 | -99.9% | 20,400,000 | -28.7% | 0.03% | -9.4% |
| Q3 2022 | $56,710,654,000 | -25.8% | 28,600,000 | +16.7% | 0.03% | -3.0% |
| Q1 2022 | $76,417,950,000 | -0.2% | 24,500,000 | +4.7% | 0.03% | +13.8% |
| Q4 2021 | $76,580,244,000 | +2.7% | 23,400,000 | +4.5% | 0.03% | -6.5% |
| Q3 2021 | $74,569,152,000 | +2.8% | 22,400,000 | -19.7% | 0.03% | 0.0% |
| Q2 2021 | $72,514,890,000 | +4.0% | 27,900,000 | -11.4% | 0.03% | 0.0% |
| Q1 2021 | $69,719,580,000 | – | 31,500,000 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Elequin Capital, LP | 11,771,000 | $26,632,270 | 5.17% |
| Calamos Advisors LLC | 30,006,000 | $67,881,974 | 0.35% |
| CAPSTONE INVESTMENT ADVISORS, LLC | 5,000,000 | $11,302,500 | 0.05% |
| D. E. Shaw & Co., Inc. | 10,000,000 | $23,351,070 | 0.02% |
| UBS ASSET MANAGEMENT AMERICAS LLC | 23,000,000 | $52,692,310 | 0.02% |
| BNP PARIBAS FINANCIAL MARKETS | 1,035,000 | $2,337,030 | 0.00% |
| LOOMIS SAYLES & CO L P | 9,739 | $909 | 0.00% |
| MORGAN STANLEY | 2,500,000 | $5,648,750 | 0.00% |
| JPMORGAN CHASE & CO | 7,065,000 | $13,564,800 | 0.00% |
| FMR LLC | 6,019,000 | $13,590,902 | 0.00% |